Biogen's former R & D boss resurfaces on board of California biotech

Verge Genomics, which is coupling human brain disease data with artificial intelligence and machine learning, looks to take its first drug into a clinical trial this year against amyotrophic lateral sclerosis.

Source: bizjournals.com Health Care:Biotechnology headlines - February 10, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news